New Molecular Mechanisms and Advanced Therapies for Solid Tumors
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Oncology".
Deadline for manuscript submissions: 31 May 2024 | Viewed by 4055
Special Issue Editor
Interests: cancer; kinase inhibitor; target therapy; signal transduction; cell cycle; mitogenesis; survival; resistance
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Solid tumors account for approximately 90% of adult human cancers. The two main types of solid tumors are sarcomas and carcinomas.
The current most common solid tumors are breast cancer, lung cancer, prostate cancer, colon cancer and skin cancer.
Treatment for solid tumors generally combines several types of therapy, which can basically include surgery, chemotherapy, and radiation therapy. With the new understanding of the molecular mechanisms of solid tumor progression, leading to the evolution of many new therapeutic regimens and their subsequent trials, targeted drug therapy, immunotherapy and personalized medicines are now widely employed.
Current precision medicine for solid tumors includes a combination of appropriate cytotoxic agents and targeted drugs for each molecular subtype. Since molecular subtypes provide appropriate therapeutic targets, various molecular subtypes have been explored for gene mutation, gene expression, and protein expression. However, this tumor heterogeneity is considered to be one of the main reasons for chemoresistance, as refractory solid tumors exhibit very high tumor heterogeneity and fail to be eradicated even when treated with different anticancer drugs.
This Special Issue aims to provide a platform for the research on new molecular mechanisms in solid tumors, with particular attention to potential new targets and treatments and therefore to new pathogenetic pathways involved in these diseases. We welcome your submissions of original papers and updated review articles based on findings from a molecular point of view.
Prof. Dr. Valentina De Falco
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- solid tumor
- kinase inhibitors
- animal model
- cell culture
- drug resistance
- signal transduction
- survival
- cell reprogramming
- pathways
- clinical trials
- target therapy
- cell cycle
- cell death inhibiting
- oncogene
- precision medicine
